Beyond Air (XAIR) Competitors

$0.40 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$0.40 0.00 (0.00%)

As of 05/22/2026 07:45 PM Eastern

XAIR vs. TMDIF, FEMY, RVP, OSRH, and ICCM

Should you buy Beyond Air stock or one of its competitors? MarketBeat compares Beyond Air with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beyond Air include Titan Medical (TMDIF), Femasys (FEMY), Retractable Technologies (RVP), OSR (OSRH), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry.

How does Beyond Air compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Beyond Air has a consensus price target of $10.00, indicating a potential upside of 2,393.77%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Beyond Air	Neutral

Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Beyond Air has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -447.75%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Beyond Air	-447.75%	-268.82%	-98.49%

Titan Medical has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.32	$6.95M	$0.05	4.08
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A

Summary

Titan Medical and Beyond Air tied by winning 7 of the 14 factors compared between the two stocks.

How does Beyond Air compare to Femasys?

Femasys (NASDAQ:FEMY) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

65.3% of Femasys shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 7.6% of Femasys shares are owned by company insiders. Comparatively, 10.0% of Beyond Air shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Femasys presently has a consensus target price of $5.33, indicating a potential upside of 1,117.66%. Beyond Air has a consensus target price of $10.00, indicating a potential upside of 2,393.77%. Given Beyond Air's higher possible upside, analysts clearly believe Beyond Air is more favorable than Femasys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Femasys has a beta of -2.26, suggesting that its stock price is 326% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market.

Beyond Air has a net margin of -447.75% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
Beyond Air	-447.75%	-268.82%	-98.49%

Femasys has higher earnings, but lower revenue than Beyond Air. Femasys is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	11.55	-$18.63M	-$0.27	N/A
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A

In the previous week, Femasys had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for Femasys and 0 mentions for Beyond Air. Femasys' average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.

Company	Overall Sentiment
Femasys	Neutral
Beyond Air	Neutral

Summary

Femasys beats Beyond Air on 9 of the 15 factors compared between the two stocks.

How does Beyond Air compare to Retractable Technologies?

Beyond Air (NASDAQ:XAIR) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Beyond Air has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market.

Retractable Technologies has a net margin of -41.11% compared to Beyond Air's net margin of -447.75%. Retractable Technologies' return on equity of -17.15% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Retractable Technologies has higher revenue and earnings than Beyond Air. Retractable Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 10.0% of Beyond Air shares are held by insiders. Comparatively, 59.5% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Beyond Air's average media sentiment score of 0.00 beat Retractable Technologies' score of -1.00 indicating that Beyond Air is being referred to more favorably in the media.

Company	Overall Sentiment
Beyond Air	Neutral
Retractable Technologies	Negative

Beyond Air currently has a consensus price target of $10.00, suggesting a potential upside of 2,393.77%. Given Beyond Air's stronger consensus rating and higher probable upside, equities research analysts plainly believe Beyond Air is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Retractable Technologies beats Beyond Air on 8 of the 15 factors compared between the two stocks.

How does Beyond Air compare to OSR?

OSR (NASDAQ:OSRH) and Beyond Air (NASDAQ:XAIR) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

OSR has higher earnings, but lower revenue than Beyond Air. OSR is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.91M	6.06	-$27.06M	-$0.33	N/A
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A

In the previous week, OSR's average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.

Company	Overall Sentiment
OSR	Neutral
Beyond Air	Neutral

Beyond Air has a consensus price target of $10.00, suggesting a potential upside of 2,393.77%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

OSR has a net margin of -363.26% compared to Beyond Air's net margin of -447.75%. OSR's return on equity of -7.24% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Beyond Air	-447.75%	-268.82%	-98.49%

55.3% of OSR shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 60.6% of OSR shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

OSR has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

Summary

OSR beats Beyond Air on 9 of the 14 factors compared between the two stocks.

How does Beyond Air compare to IceCure Medical?

Beyond Air (NASDAQ:XAIR) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

IceCure Medical has a net margin of -441.60% compared to Beyond Air's net margin of -447.75%. IceCure Medical's return on equity of -211.73% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
IceCure Medical	-441.60%	-211.73%	-119.13%

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Comparatively, 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

IceCure Medical has lower revenue, but higher earnings than Beyond Air. IceCure Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.43	-$46.62M	-$5.43	N/A
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A

In the previous week, IceCure Medical had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for IceCure Medical and 0 mentions for Beyond Air. IceCure Medical's average media sentiment score of 0.61 beat Beyond Air's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Beyond Air	Neutral
IceCure Medical	Positive

Beyond Air presently has a consensus target price of $10.00, indicating a potential upside of 2,393.77%. IceCure Medical has a consensus target price of $2.09, indicating a potential upside of 789.36%. Given Beyond Air's higher probable upside, research analysts clearly believe Beyond Air is more favorable than IceCure Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Beyond Air has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market.

Summary

IceCure Medical beats Beyond Air on 10 of the 16 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.29M	$3.37B	$6.46B	$12.34B
Dividend Yield	N/A	2.26%	2.76%	5.28%
P/E Ratio	-0.07	18.74	20.99	25.66
Price / Sales	1.43	323.98	560.30	86.31
Price / Cash	N/A	125.17	43.49	56.67
Price / Book	0.12	7.09	10.41	7.14
Net Income	-$46.62M	$24.45M	$3.57B	$335.98M
7 Day Performance	-7.00%	6.38%	6.41%	4.15%
1 Month Performance	-21.37%	2.43%	3.55%	2.54%
1 Year Performance	-89.45%	62.98%	34.12%	35.06%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	2.1724 of 5 stars	$0.40 flat	$10.00 +2,393.8%	-89.4%	$5.29M	$3.70M	N/A	70	Gap Up
TMDIF Titan Medical	N/A	$0.20 -10.3%	N/A	-26.0%	$22.92M	$17.63M	N/A	50	Gap Down
FEMY Femasys	2.1398 of 5 stars	$0.36 -1.2%	$5.33 +1,387.3%	-57.9%	$21.91M	$2.29M	N/A	30	Gap Down
RVP Retractable Technologies	N/A	$0.68 +1.6%	N/A	+9.9%	$20.39M	$38.27M	N/A	240	Negative News Gap Down
OSRH OSR	0.4728 of 5 stars	$0.51 -2.4%	N/A	-56.7%	$18.35M	$2.91M	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. TMDIF, FEMY, RVP, OSRH, and ICCM

How does Beyond Air compare to Titan Medical?

Summary

How does Beyond Air compare to Femasys?

Summary

How does Beyond Air compare to Retractable Technologies?

Summary

How does Beyond Air compare to OSR?

Summary

How does Beyond Air compare to IceCure Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. TMDIF, FEMY, RVP, OSRH, and ICCM

How does Beyond Air compare to Titan Medical?

Do analysts prefer TMDIF or XAIR?

Does the media prefer TMDIF or XAIR?

Which has more volatility and risk, TMDIF or XAIR?

Do insiders and institutionals have more ownership in TMDIF or XAIR?

Is TMDIF or XAIR more profitable?

Which has stronger valuation and earnings, TMDIF or XAIR?

Summary

How does Beyond Air compare to Femasys?

Do institutionals and insiders have more ownership in FEMY or XAIR?

Do analysts recommend FEMY or XAIR?

Which has more volatility and risk, FEMY or XAIR?

Is FEMY or XAIR more profitable?

Which has preferable valuation & earnings, FEMY or XAIR?

Does the media prefer FEMY or XAIR?

Summary

How does Beyond Air compare to Retractable Technologies?

Which has more risk and volatility, XAIR or RVP?

Is XAIR or RVP more profitable?

Which has better valuation & earnings, XAIR or RVP?

Do insiders and institutionals have more ownership in XAIR or RVP?

Does the media favor XAIR or RVP?

Do analysts rate XAIR or RVP?

Summary

How does Beyond Air compare to OSR?

Which has stronger earnings and valuation, OSRH or XAIR?

Does the media prefer OSRH or XAIR?

Do analysts rate OSRH or XAIR?

Is OSRH or XAIR more profitable?

Do institutionals & insiders hold more shares of OSRH or XAIR?

Which has more volatility and risk, OSRH or XAIR?

Summary

How does Beyond Air compare to IceCure Medical?

Is XAIR or ICCM more profitable?

Do insiders & institutionals believe in XAIR or ICCM?

Which has preferable earnings & valuation, XAIR or ICCM?

Does the media favor XAIR or ICCM?

Do analysts rate XAIR or ICCM?

Which has more risk & volatility, XAIR or ICCM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools